nadp has been researched along with Hyperuricemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aal, M; Abdel-Ghany, RH; Alsemeh, AE; Ghareib, SA; Wahba, NS | 1 |
| Ichida, K | 1 |
1 review(s) available for nadp and Hyperuricemia
| Article | Year |
|---|---|
[Hyperuricemia and metabolic syndrome].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Fructose; Humans; Hyperuricemia; Insulin Resistance; Kidney Tubules; Liver; Metabolic Syndrome; NADP; Obesity; Organic Anion Transporters; Organic Cation Transport Proteins; Purines; Sodium; Uric Acid | 2010 |
1 other study(ies) available for nadp and Hyperuricemia
| Article | Year |
|---|---|
Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Cholecalciferol; Creatinine; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hyperuricemia; Hypoglycemic Agents; Insulin Resistance; Kidney; Kidney Cortex; Male; Malondialdehyde; MAP Kinase Signaling System; NADP; Oxidative Stress; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sirtuin 1; Sodium Chloride; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Urea; Uric Acid; Vildagliptin | 2020 |